Reaction
Limbic Encephalitis reporting signals
As of the last recalculation, Limbic Encephalitis appears in 276 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ATEZOLIZUMAB (PRR 39.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Atezolizumab | 19 | 39.6 | 39.6 |
| Axicabtagene Ciloleucel | 3 | 23.2 | 23.2 |
| Durvalumab | 5 | 18.9 | 18.9 |